JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levi, R.
Right arrow Articles by Smith, N. C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levi, R.
Right arrow Articles by Smith, N. C. E.

Vol. 292, Issue 3, 825-830, March 2000

Histamine H3-Receptors: A New Frontier in Myocardial Ischemia

Roberto Levi and Neil C. E. Smith

Department of Pharmacology, Cornell University, Weill Medical College, New York, New York

In protracted myocardial ischemia, sympathetic nerve endings undergo ATP depletion, hypoxia and pHi reduction. Consequently, norepinephrine (NE) accumulates in the axoplasm, because it is no longer stored in synaptic vesicles, and intraneuronal Na+ concentration increases, as the Na+/H+ exchanger (NHE) is activated. This forces the reversal of the Na+- and Cl--dependent NE transporter, triggering a massive carrier-mediated release of NE and thus, arrhythmias. Indeed, NE overflow in myocardial ischemia directly correlates with the severity of arrhythmias. Histamine H3-receptors (H3R) have been identified as inhibitory heteroreceptors in adrenergic nerve endings of the heart. In addition to inhibiting NE exocytosis from sympathetic nerve endings, selective H3R agonists attenuate carrier-mediated release of NE in both animal and human models of protracted myocardial ischemia. Whereas H3R-mediated attenuation of exocytotic NE release involves an inhibition of N-type Ca2+-channels, H3R-mediated reduction of carrier-mediated NE release is associated with diminished NHE activity. In addition to inhibiting NE release, H3R stimulation significantly attenuates the incidence and duration of ventricular fibrillation. Although other presynaptic receptors also modulate NE release from sympathetic nerve endings, H3R stimulation reduces both exocytotic and carrier-mediated NE release, whereas alpha 2-adrenoceptor agonists attenuate NE exocytosis but enhance carrier-mediated NE release. Furthermore, unlike adenosine A1-receptors, whose activation reduces both exocytotic and carrier-mediated NE release, H3R stimulation is devoid of negative chronotropic and dromotropic effects (i.e., sinoatrial and atrioventricular nodal functions are unaffected). Because excess NE release can trigger severe arrhythmias and sudden cardiac death, negative modulation of NE release by H3R agonists may offer a novel therapeutic approach to myocardial ischemia.


0022-3565/00/2923-0825$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
C. Morrey, R. Estephan, G. W. Abbott, and R. Levi
Cardioprotective Effect of Histamine H3-Receptor Activation: Pivotal Role of G{beta}{gamma}-Dependent Inhibition of Voltage-Operated Ca2+ Channels
J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 871 - 878.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. M. Gardiner, J. E. March, P. A. Kemp, and T. Bennett
A Comparison between the Cardiovascular Actions of Urocortin 1 and Urocortin 2 (Stresscopin-Related Peptide) in Conscious Rats
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 221 - 226.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
U. Schaefer, T. Machida, S. Vorlova, S. Strickland, and R. Levi
The plasminogen activator system modulates sympathetic nerve function
J. Exp. Med., September 4, 2006; 203(9): 2191 - 2200.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
P. J. Harvey, X. Li, Y. Li, and D. J. Bennett
Endogenous Monoamine Receptor Activation Is Essential for Enabling Persistent Sodium Currents and Repetitive Firing in Rat Spinal Motoneurons
J Neurophysiol, September 1, 2006; 96(3): 1171 - 1186.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. F. Pedersen, M. E. O'Donnell, S. E. Anderson, and P. M. Cala
Physiology and pathophysiology of Na+/H+ exchange and Na+-K+-2Cl- cotransport in the heart, brain, and blood
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R1 - R25.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Li, J. Hu, Z. Chen, J. Meng, H. Wang, X. Ma, and X. Luo
Evidence for histamine as a neurotransmitter in the cardiac sympathetic nervous system
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H45 - H51.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Machida, P. M. Heerdt, A. C. Reid, U. Schafer, R. B. Silver, M. J. Broekman, A. J. Marcus, and R. Levi
Ectonucleoside Triphosphate Diphosphohydrolase1/CD39, Localized in Neurons of Human and Porcine Heart, Modulates ATP-Induced Norepinephrine Exocytosis
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 570 - 577.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Yamamoto, N. Matsumoto, M. Kanazawa, M. Fujita, M. Takaoka, C. E. Gariepy, M. Yanagisawa, and Y. Matsumura
Different Contributions of Endothelin-A and Endothelin-B Receptors in Postischemic Cardiac Dysfunction and Norepinephrine Overflow in Rat Hearts
Circulation, January 25, 2005; 111(3): 302 - 309.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Seyedi, C. J. Mackins, T. Machida, A. C. Reid, R. B. Silver, and R. Levi
Histamine H3-Receptor-Induced Attenuation of Norepinephrine Exocytosis: A Decreased Protein Kinase A Activity Mediates a Reduction in Intracellular Calcium
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 272 - 280.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Burgdorf, A. Dendorfer, T. Kurz, E. Schomig, I. Stolting, F. Schutte, and G. Richardt
Role of Neuronal KATP Channels and Extraneuronal Monoamine Transporter on Norepinephrine Overflow in a Model of Myocardial Low Flow Ischemia
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 42 - 48.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. C. Reid, C. J. Mackins, N. Seyedi, R. Levi, and R. B. Silver
Coupling of angiotensin II AT1 receptors to neuronal NHE activity and carrier-mediated norepinephrine release in myocardial ischemia
Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1448 - H1454.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Sesti, M. Koyama, M. J. Broekman, A. J. Marcus, and R. Levi
Ectonucleotidase in Sympathetic Nerve Endings Modulates ATP and Norepinephrine Exocytosis in Myocardial Ischemia
J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 238 - 244.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Raasch, B. Jungbluth, U. Schafer, W. Hauser, and P. Dominiak
Modification of Noradrenaline Release in Pithed Spontaneously Hypertensive Rats by I1-Binding Sites in Addition to alpha 2-Adrenoceptors
J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1063 - 1071.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Koyama, N. Seyedi, W.-P. Fung-Leung, T. W. Lovenberg, and R. Levi
Norepinephrine Release from the Ischemic Heart Is Greatly Enhanced in Mice Lacking Histamine H3 Receptors
Mol. Pharmacol., February 1, 2003; 63(2): 378 - 382.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J.-i. Oka, M. Imamura, E. Hatta, R. Maruyama, M. Isaka, T. Murashita, and K. Yasuda
Carrier-Mediated Norepinephrine Release and Reperfusion Arrhythmias Induced by Protracted Ischemia in Isolated Perfused Guinea Pig Hearts: Effect of Presynaptic Modulation by alpha 2-Adrenoceptor in Mild Hypothermic Ischemia
J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 681 - 687.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Seyedi, M. Koyama, C. J. Mackins, and R. Levi
Ischemia Promotes Renin Activation and Angiotensin Formation in Sympathetic Nerve Terminals Isolated from the Human Heart: Contribution to Carrier-Mediated Norepinephrine Release
J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 539 - 544.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Huang, X. Pang, R. Letourneau, W. Boucher, and T. C Theoharides
Acute stress induces cardiac mast cell activation and histamine release, effects that are increased in Apolipoprotein E knockout mice
Cardiovasc Res, July 1, 2002; 55(1): 150 - 160.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. Boehm and H. Kubista
Fine Tuning of Sympathetic Transmitter Release via Ionotropic and Metabotropic Presynaptic Receptors
Pharmacol. Rev., March 1, 2002; 54(1): 43 - 99.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Yamasaki, I. Tamai, and Y. Matsumura
Activation of histamine H3 receptors inhibits renal noradrenergic neurotransmission in anesthetized dogs
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1450 - R1456.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. B. Silver, C. J. Mackins, N. C. E. Smith, I. L. Koritchneva, K. Lefkowitz, T. W. Lovenberg, and R. Levi
Coupling of histamine H3 receptors to neuronal Na+/H+ exchange: A novel protective mechanism in myocardial ischemia
PNAS, February 15, 2001; (2001) 51599198.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Maruyama, E. Hatta, K. Yasuda, N. C. E. Smith, and R. Levi
Angiotensin-Converting Enzyme-Independent Angiotensin Formation in a Human Model of Myocardial Ischemia: Modulation of Norepinephrine Release by Angiotensin Type 1 and Angiotensin Type 2 Receptors
J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 248 - 254.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. B. Silver, K. S. Poonwasi, N. Seyedi, S. J. Wilson, T. W. Lovenberg, and R. Levi
Decreased intracellular calcium mediates the histamine H3-receptor-induced attenuation of norepinephrine exocytosis from cardiac sympathetic nerve endings
PNAS, January 8, 2002; 99(1): 501 - 506.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. B. Silver, C. J. Mackins, N. C. E. Smith, I. L. Koritchneva, K. Lefkowitz, T. W. Lovenberg, and R. Levi
Coupling of histamine H3 receptors to neuronal Na+/H+ exchange: A novel protective mechanism in myocardial ischemia
PNAS, February 27, 2001; 98(5): 2855 - 2859.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
C. L. Brett, Y. Wei, M. Donowitz, and R. Rao
Human Na+/H+ exchanger isoform 6 is found in recycling endosomes of cells, not in mitochondria
Am J Physiol Cell Physiol, May 1, 2002; 282(5): C1031 - C1041.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.